Matches in Nanopublications for { ?s ?p "[In this study, we analyzed 320 thyroid tumors and six anaplastic carcinoma cell lines and detected BRAF mutations in 45 (38%) papillary carcinomas, two (13%) poorly-differentiated carcinomas, three (10%) anaplastic carcinomas, and five (83%) thyroid anaplastic carcinoma cell lines but not in follicular, H�rthle cell, and medullary carcinomas, follicular and H�rthle cell adenomas, or benign hyperplastic nodules.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP272212.RAYK4vYWwXpXSfdqITd4GlmW06Zm7B6AxIt9uxA1FwnO0130_assertion description "[In this study, we analyzed 320 thyroid tumors and six anaplastic carcinoma cell lines and detected BRAF mutations in 45 (38%) papillary carcinomas, two (13%) poorly-differentiated carcinomas, three (10%) anaplastic carcinomas, and five (83%) thyroid anaplastic carcinoma cell lines but not in follicular, H�rthle cell, and medullary carcinomas, follicular and H�rthle cell adenomas, or benign hyperplastic nodules.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP272212.RAYK4vYWwXpXSfdqITd4GlmW06Zm7B6AxIt9uxA1FwnO0130_provenance.
- NP924814.RAMkmzpP4vvIVwa_kwVOfK9CFTsbTs0s6efZ-E17M2cF0130_assertion description "[In this study, we analyzed 320 thyroid tumors and six anaplastic carcinoma cell lines and detected BRAF mutations in 45 (38%) papillary carcinomas, two (13%) poorly-differentiated carcinomas, three (10%) anaplastic carcinomas, and five (83%) thyroid anaplastic carcinoma cell lines but not in follicular, H�rthle cell, and medullary carcinomas, follicular and H�rthle cell adenomas, or benign hyperplastic nodules.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP924814.RAMkmzpP4vvIVwa_kwVOfK9CFTsbTs0s6efZ-E17M2cF0130_provenance.
- NP419502.RAW4Xi0JE1I_k7mcN09xdQ9dzCHhiLrYf1cf1myMlk6a4130_assertion description "[In this study, we analyzed 320 thyroid tumors and six anaplastic carcinoma cell lines and detected BRAF mutations in 45 (38%) papillary carcinomas, two (13%) poorly-differentiated carcinomas, three (10%) anaplastic carcinomas, and five (83%) thyroid anaplastic carcinoma cell lines but not in follicular, H�rthle cell, and medullary carcinomas, follicular and H�rthle cell adenomas, or benign hyperplastic nodules.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419502.RAW4Xi0JE1I_k7mcN09xdQ9dzCHhiLrYf1cf1myMlk6a4130_provenance.
- NP272172.RAJgmYKcWxNLk7WNQQ_dXfyA-guzLwOSl_hNelylK8AKE130_assertion description "[In this study, we analyzed 320 thyroid tumors and six anaplastic carcinoma cell lines and detected BRAF mutations in 45 (38%) papillary carcinomas, two (13%) poorly-differentiated carcinomas, three (10%) anaplastic carcinomas, and five (83%) thyroid anaplastic carcinoma cell lines but not in follicular, H�rthle cell, and medullary carcinomas, follicular and H�rthle cell adenomas, or benign hyperplastic nodules.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP272172.RAJgmYKcWxNLk7WNQQ_dXfyA-guzLwOSl_hNelylK8AKE130_provenance.
- NP419504.RA3LGXdgGSmuD38o-te1tuqo0x_wPougYcYn6bh-8Uw7M130_assertion description "[In this study, we analyzed 320 thyroid tumors and six anaplastic carcinoma cell lines and detected BRAF mutations in 45 (38%) papillary carcinomas, two (13%) poorly-differentiated carcinomas, three (10%) anaplastic carcinomas, and five (83%) thyroid anaplastic carcinoma cell lines but not in follicular, H�rthle cell, and medullary carcinomas, follicular and H�rthle cell adenomas, or benign hyperplastic nodules.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419504.RA3LGXdgGSmuD38o-te1tuqo0x_wPougYcYn6bh-8Uw7M130_provenance.